Why EverydayMeds Offers the UK's Most Competitive Rates
Wegovy or Mounjaro Price Comparison: UK's Most Transparent Rates
When comparing Wegovy or Mounjaro pricing across the UK, most providers hide consultation fees, delivery charges, or prescription costs within their final prices. EverydayMeds breaks this pattern by offering complete price transparency from the start. Our Wegovy pricing begins at £79.99 for the 0.25mg starter dose, with all consultation, prescription, and next-day delivery costs included. Mounjaro pricing follows a similarly transparent structure, ensuring you understand exactly what you're paying for without surprise additions at checkout.
The key difference in our pricing approach for both Wegovy or Mounjaro lies in our bundle options designed around real patient needs. Rather than forcing you to buy individual pens repeatedly, our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg Wegovy) at £169.99 provide seamless dose progression. For those seeking maintenance supply, our Ultimate Stability Trio delivers three months of 2.4mg Wegovy for £649.99, offering both convenience and supply security that individual purchases cannot match.
Complete Value Breakdown: What's Included in Wegovy or Mounjaro Pricing
Every Wegovy or Mounjaro purchase from EverydayMeds includes comprehensive clinical assessment, qualified prescriber review, prescription issue, and temperature-controlled delivery — services that many competitors charge separately. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access our published rates. This integrated approach means your £79.99 Wegovy starter dose or equivalent Mounjaro prescription represents complete healthcare delivery, not just medication supply.
Our pricing structure reflects the reality of prescription-only medicine management in the UK. Both Wegovy or Mounjaro require ongoing clinical oversight, dose adjustments, and careful monitoring — costs we've built into transparent pricing rather than charging as separate services. This approach particularly benefits patients progressing through dose escalation phases, where multiple prescriber consultations with other providers can quickly multiply costs beyond the base medication price.
Clinical Evidence Supporting Wegovy or Mounjaro Treatment Decisions
When evaluating Wegovy or Mounjaro from a clinical perspective, both treatments demonstrated significant weight management support in their respective trials. Wegovy's STEP programme, particularly STEP 1 (Wilding et al., NEJM, 2021), showed patients taking semaglutide alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks. Mounjaro's SURMOUNT trials indicated that tirzepatide may support similar weight management outcomes, though direct comparison between trials isn't appropriate due to different study designs.
The SELECT cardiovascular outcomes trial adds another dimension to Wegovy evaluation, demonstrating a 20% reduction in major cardiovascular events alongside weight management benefits. These clinical foundations support why both Wegovy or Mounjaro have earned NICE recommendations and MHRA approval as prescription-only medicines for weight management when used appropriately under clinical supervision.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management efforts. When you inject Wegovy weekly using the FlexTouch pen, it may help reduce appetite and promote feelings of fullness after smaller meals, potentially making it easier to maintain a reduced-calorie diet. The medication works on brain appetite centres, which may help reduce food cravings and the constant thoughts about food that often undermine weight management attempts. This mechanism means Wegovy functions as a tool alongside dietary changes and increased physical activity, rather than replacing lifestyle modifications. The once-weekly injection schedule provides consistent support throughout your week, helping maintain steady appetite regulation as you progress through your weight management journey.
Streamlined Ordering Process for Wegovy or Mounjaro
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our 3-minute online clinical assessment, designed to gather essential health information efficiently without unnecessary complexity. Once submitted, your assessment undergoes review by our qualified prescribing team within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight for these prescription-only medicines. Upon approval, your chosen treatment ships via next-day delivery using cold-chain transport to maintain the 2-8°C temperature requirements both medications require. Our GPhC-registered pharmacy (#9012878) handles all prescription processing, medication dispensing, and delivery coordination as integrated services. This streamlined approach eliminates the multiple appointments, waiting periods, and separate delivery arrangements that traditional healthcare pathways often require for accessing Wegovy or Mounjaro.
Storage and Practical Considerations for Wegovy or Mounjaro
Both Wegovy or Mounjaro require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability once removed from the fridge, compared to Mounjaro's 21-day limit. The Wegovy FlexTouch pen delivers pre-measured doses through a simple injection process, with mandatory dose escalation from 0.25mg through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose. This escalation cannot be skipped and typically takes 16 weeks to complete, making our bundle options particularly valuable for ensuring consistent supply throughout your dose progression. Both treatments require weekly injections on the same day each week, with flexibility to adjust timing by up to 3 days if needed. The pen design makes self-administration straightforward, though proper injection technique training is included with your first prescription to ensure optimal results and comfort.
Why UK Price Transparency Matters for Wegovy or Mounjaro Decisions
The UK weight management market often obscures true treatment costs through complex pricing structures that separate consultation, prescription, and delivery fees. This fragmentation makes comparing Wegovy or Mounjaro costs across providers nearly impossible until you've committed to their process. EverydayMeds addresses this transparency gap by publishing complete treatment costs upfront, including all necessary clinical services within our listed prices.
This pricing clarity becomes particularly important for long-term weight management planning, where both Wegovy or Mounjaro require ongoing prescription renewals and clinical monitoring. Understanding your monthly treatment investment from the start enables better budgeting decisions and eliminates the anxiety of unknown costs accumulating over time. Our bundle pricing structure further supports this transparency by clearly showing progression costs and maintenance supply options without hidden calculations or surprise additions.
Secure Your Wegovy or Mounjaro Supply at UK's Best Rates
Starting your weight management journey with either Wegovy or Mounjaro shouldn't be complicated by pricing uncertainty or supply concerns. EverydayMeds combines the UK's most competitive rates with reliable prescription-only medicine supply through our established clinical pathways and cold-chain delivery network. Apply code FIRST40 at checkout for new customer pricing, or use DOSE25 for returning patient rates — both codes access the published prices throughout this page. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, knowing you're accessing genuine prescription treatments at verified lowest UK pricing. Our clinical team provides ongoing support throughout your treatment journey, ensuring your Wegovy or Mounjaro experience delivers both value and results under appropriate medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
